Paper Details
- Home
- Paper Details
Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation.
Author: Guzman-AranguezAna, KaurIndu Pal, Perez de LaraMaria J, SinghJoga, SinghMandeep, YadavMonika
Original Abstract of the Article :
Primary treatment for glaucoma relies on chronic instillation (daily) of intraocular pressure (IOP) lowering eye drops. Present study tends to develop and assess a novel sustained release bimatoprost loaded nanovesicular (BMT-NV) - thermosensitive in-situ gelling implant (BMT-NV-GEL-IM), for subconj...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.msec.2019.05.015
データ提供：米国国立医学図書館（NLM）
Bimatoprost-Loaded Nanovesicular Implant: An Oasis of Hope for Glaucoma Treatment
Glaucoma, a condition that can lead to irreversible vision loss, requires ongoing management, often involving daily eye drops. This study explores the potential of a novel, long-acting bimatoprost-loaded nanovesicular implant for subconjunctival delivery, seeking to reduce the burden of frequent eye drops. The researchers developed and evaluated this implant, finding that it effectively lowered intraocular pressure (IOP) over an extended period, offering a promising alternative for glaucoma treatment. The findings provide a potential oasis of hope in the desert of glaucoma management.
A New Oasis of Relief: Long-Acting Bimatoprost Implant
This study highlights the potential of a novel bimatoprost-loaded nanovesicular implant to effectively lower IOP over an extended period, providing a promising alternative to daily eye drops for glaucoma management. The researchers’ findings demonstrate the implant’s effectiveness in lowering IOP and its potential to significantly reduce the burden of frequent eye drops. The study offers a beacon of hope in the desert of glaucoma treatment, potentially improving patient outcomes and quality of life.
Finding a More Comfortable Path: Navigating Glaucoma Treatment
This study emphasizes the importance of exploring new approaches to glaucoma treatment, seeking to reduce the burden of frequent eye drops and improve patient compliance. The researchers’ findings demonstrate the potential of a novel bimatoprost-loaded nanovesicular implant to effectively lower IOP over an extended period, offering a more comfortable and convenient path for patients navigating the desert of glaucoma management.
Dr. Camel's Conclusion
This study delves into the potential of a novel bimatoprost-loaded nanovesicular implant to effectively lower IOP over an extended period, offering a promising alternative to daily eye drops for glaucoma management. The study’s findings offer a beacon of hope in the desert of glaucoma treatment, potentially improving patient outcomes and quality of life.
Date :
- Date Completed 2019-12-30
- Date Revised 2019-12-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.